The Patent Finder

Terms ending in 2041

Bayer Pharma Aktiengesellschaft

Every in-force patent on Bayer Pharma Aktiengesellschaft's record whose computed term ends in 2041, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 11,905,270Carboxylic Acid Aromatic Amides as Antagonists of Bradykinin B1 Receptor
In force
 · High confidence
Bayer Pharma AktiengesellschaftIn forceHigh confidence
US 11,884,660A Substituted Oxopyridine Derivative
In force
 · High confidence
Bayer Pharma AktiengesellschaftIn forceHigh confidence
US 12,054,481Method for the Preparation of (4S)-4-(4-Cyano-2-Methoxyphenyl)-5-Ethoxy-2,8-Dimethyl-1,4-Dihydro-1-6-Naphthyridine-3-Carbox-AMIDE by Racemate Separation by Means of Diastereomeric Tartaric Acid Esters
In force
 · High confidence
Bayer Aktiengesellschaft and Bayer Pharma AktiengesellschaftIn forceHigh confidence
3 of 3 patents shown. Soonest term end first, then patent number.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited